CTRI/2024/04/065462
Not yet recruiting
Phase 3
Randomized controlled trial to evaluate efficacy of panchavalkal kwath yonidhavan, panchavalkal taila yonipitchu and combination of both on garbhashay griva gat vrana with special reference to cervical erosion - NI
Dr Archana Subhash Jadhav0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteri
- Sponsor
- Dr Archana Subhash Jadhav
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Married patients
- •Cervical errosion
- •Chronic cervicitis
- •Bacterial vaginosis
Exclusion Criteria
- •Venereal disease
- •Diabetes Malitus
- •Patient taking harmonal drug
- •Patient with IUCD and on oral contraceptive pills
- •Suspected cases of CA cervix
- •Patient reactive with HIV,HbsAg,HIV
- •Cervical tumour, polyp, fibroid
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Additional synbiotics to combination therapy with immune checkpoint inhibitors for unresectable or recurrent gastric and esophageal cancerGastric cancer , esophageal cancerJPRN-jRCTs051230063Kurokawa Yukinori244
Not yet recruiting
Phase 2
Ayurvedic Sukhaprasavkar lepa to facilitate Normal childbirth.Health Condition 1: O610- Failed medical induction of laborCTRI/2024/05/067385one
Not yet recruiting
Phase 2
Study of effect of Patolmooladi kashay orally and external application of aaragwadhadi lepa in skin disease.Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2020/03/024370Dr Prajakta Prabhakar Kulkarni
Completed
Phase 2
Clinical Trial of plant protein source in comparison with whey protein concentrate(80%)CTRI/2022/08/044843Medizen Labs Pvt Ltd60
Completed
Phase 2
A study to evaluate the efficacy of Kapitthadi lotion as compared to Standard care of treatment on hair loss due to ChemotherapyHealth Condition 1: D099- Carcinoma in situ, unspecifiedCTRI/2022/03/041126Dr Prapti Puddatwar50